Insights

Strong Q2 Growth PTC Therapeutics reported quarterly revenue of approximately 360.52 million in Q2 2026, beating consensus estimates and showcasing rapid top line expansion. This indicates a growing commercial footprint and potential for expanded access programs or broader product collaboration discussions.

Fabry Program Acquisition PTC acquired Sangamo's Fabry disease program isaralgagene civaparvovec (ST-920) for 111 million in cash plus up to 100 million in potential milestones, signaling an interest in expanding its rare disease portfolio and potential cross-sell or licensing conversations with specialty clinics and patient organizations.

Board & Leadership Signals Recent board appointment of Jessica Chutter and ongoing investor outreach including J.P. Morgan Healthcare Conference participation suggest an active governance and fundraising posture, presenting opportunities to engage with investors and strategic partners focused on growth initiatives and potential collaborations.

Awards & Talent PTC earned Gallup's Exceptional Workplace Award for the fifth year, indicating a strong employer brand and potential to attract top specialized talent and partner ecosystems; leverage for partner credibility in joint development programs and clinical operations.

Global Commercial Outlook With a sizable workforce and a broad funding base, and given the independent success in exceeding revenue expectations, there are opportunities to explore partnerships for global market access, manufacturing scale, and distribution capabilities to accelerate commercialization of rare disease therapies.

Similar companies to PTC Therapeutics, Inc.

PTC Therapeutics, Inc. Tech Stack

PTC Therapeutics, Inc. uses 8 technology products and services including Nessus, Adobe Creative Cloud, Canva, and more. Explore PTC Therapeutics, Inc.'s tech stack below.

Media & News

PTC Therapeutics, Inc.'s Email Address Formats

PTC Therapeutics, Inc. uses at least 4 email formats:
PTC Therapeutics, Inc. Email FormatsExamplePercentage
FLast@ptcbio.comJDoe@ptcbio.com
93%
FirstLast@ptcbio.comJohnDoe@ptcbio.com
3%
First.Last@ptcbio.comJohn.Doe@ptcbio.com
3%
FMiddleLast@ptcbio.comJMichaelDoe@ptcbio.com
1%

Frequently Asked Questions

What is PTC Therapeutics, Inc.'s phone number?

Minus sign iconPlus sign icon
You can contact PTC Therapeutics, Inc.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is PTC Therapeutics, Inc.'s stock symbol?

Minus sign iconPlus sign icon
PTC Therapeutics, Inc. is a publicly traded company; the company's stock symbol is PTCT.

What is PTC Therapeutics, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
PTC Therapeutics, Inc.'s official website is ptcbio.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does PTC Therapeutics, Inc. generate?

Minus sign iconPlus sign icon
As of October 2026, PTC Therapeutics, Inc.'s annual revenue is estimated to be $1B - $10B.

What is PTC Therapeutics, Inc.'s SIC code and NAICS code?

Minus sign iconPlus sign icon
PTC Therapeutics, Inc.'s SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does PTC Therapeutics, Inc. have currently?

Minus sign iconPlus sign icon
As of October 2026, PTC Therapeutics, Inc. has approximately 1.1K employees across 5 continents, including North America, Europe and South America. Key team members include Chief Commercial Officer: M. R., Chief Operating Officer: W. J. and Vice President & General Manager Europe - Commercial: K. K. S. Explore PTC Therapeutics, Inc.'s employee directory with LeadIQ.

What industry does PTC Therapeutics, Inc. belong to?

Minus sign iconPlus sign icon
PTC Therapeutics, Inc. operates in the Biotechnology Research industry.

What technology does PTC Therapeutics, Inc. use?

Minus sign iconPlus sign icon
PTC Therapeutics, Inc.'s tech stack includes Nessus, Adobe Creative Cloud, Canva, SAS, Amazon Web Services, CrowdStrike, SuccessFactors and Cisco Meraki.

What is PTC Therapeutics, Inc.'s email format?

Minus sign iconPlus sign icon
PTC Therapeutics, Inc.'s email format typically follows the pattern of FLast@ptcbio.com. Find more PTC Therapeutics, Inc. email formats with LeadIQ.

How much funding has PTC Therapeutics, Inc. raised to date?

Minus sign iconPlus sign icon
As of October 2026, PTC Therapeutics, Inc. has raised $1.6B in funding. The last funding round occurred on Oct 27, 2022 for $1B.

When was PTC Therapeutics, Inc. founded?

Minus sign iconPlus sign icon
PTC Therapeutics, Inc. was founded in 1998.
PTC Therapeutics, Inc. logo

PTC Therapeutics, Inc.

Biotechnology ResearchUnited States1001-5000 Employees

PTC Therapeutics is a United States-based biopharmaceutical company focused on discovering, developing, and commercializing medicines for rare and serious diseases that affect both children and adults. Its work centers on addressing patient needs through research and development to bring therapies to those with unmet medical conditions. One program in its pipeline, PTC-518, is in Phase 2 development.

The company is headquartered in Warren, New Jersey, and employs several thousand people. In March 2026, PTC announced the appointment of Jessica Chutter to its board of directors.

Section iconCompany Overview

Phone number
Website
ptcbio.com
SIC Code
8731 - Commercial Physical and Biological Research
Stock Symbol
PTCT
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
1998
Employees
1001-5000

Section iconFunding & Financials

  • $1.6B

    PTC Therapeutics, Inc. has raised a total of $1.6B of funding over 15 rounds. Their latest funding round was raised on Oct 27, 2022 in the amount of $1B as a Post IPO Equity.

  • $1B - $10B

    PTC Therapeutics, Inc.'s revenue is estimated to be in the range of $1B - $10B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.